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Abstract
 
Insulin resistance is often associated with atherosclerotic
diseases in subjects with obesity and impaired glucose toler-
ance. This study examined the effects of insulin resistance
on coronary risk factors in IRS-1 deficient mice, a nonobese
animal model of insulin resistance. Blood pressure and
plasma triglyceride levels were significantly higher in IRS-1
deficient mice than in normal mice. Impaired endothelium-
dependent vascular relaxation was also observed in IRS-1
deficient mice. Furthermore, lipoprotein lipase activity was
lower than in normal mice, suggesting impaired lipolysis to
be involved in the increase in plasma triglyceride levels un-
der insulin-resistant conditions. Thus, insulin resistance
plays an important role in the clustering of coronary risk
factors which may accelerate the progression of atheroscle-
rosis in subjects with insulin resistance. (
 
J. Clin. Invest.
 
1998. 101:1784–1788.) Key words: insulin resistance 
 
•
 
 hyper-
tension 
 
•
 
 hypertriglyceridemia 
 
•
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Introduction
 
Insulin receptor substrate-1 (IRS-1)
 
1
 
 is the major substrate of
the insulin receptor and insulin-like growth factor (IGF)-1 re-
ceptor tyrosine kinase (1, 2). Recent studies have established a
homozygous mouse model for targeted disruption of the IRS-1
gene (3, 4). IRS-1 mutant mice show retarded embryonal and
postnatal growth and develop resistance to glucose-lowering
effects of insulin, IGF-1, and IGF-2. Although blood glucose
levels do not differ significantly between mutant and control
mice either before or after oral glucose loading, serum insulin
levels are significantly higher in homozygous mutant mice than
in wild-type or heterozygous mice. Thus, the phenotype of
IRS-1 knockout mice resembles non–insulin-dependent diabe-
tes mellitus at the prediabetes stage with insulin resistance.
Insulin resistance with hyperinsulinemia is often associated
with clustering of coronary risk factors including hypertension,
glucose intolerance, obesity, hypertriglyceridemia, and low
plasma HDL-cholesterol levels (5–7). This leads to an in-
creased risk of cardiovascular disease, presumably due to pro-
motion of atherosclerosis. However, the mechanisms associ-
ated with this clustering of coronary risk factors in subjects
with insulin resistance are not clearly understood. In particu-
lar, the specific role of insulin resistance or hyperinsulinemia
needs to be clarified. Recently, we developed an animal model
of hyperinsulinemia by transplanting a second pancreas into
normal rats in order to determine whether increased plasma
insulin levels are related to the clustering of coronary risk fac-
tors and accelerated progression of atherosclerosis (8). The
model shows an endogenous insulin level twice that of normal
rats, which influences the process of atherosclerosis by enhanc-
ing accumulation of cholesterol esters in the arterial wall.
However, this level of insulin shows no relationship to dyslip-
idemia or hypertension. This study examines whether this clus-
tering syndrome is affected by insulin resistance in nonobese
IRS-1 deficient mice.
 
Methods
 
Animals and animal treatment.
 
Female mice homozygous for tar-
geted disruption of the IRS-1 gene and female wild-type mice that
were offspring of heterozygous mice were examined. The genotype of
the mice was confirmed by PCR. All mice were fed normal laboratory
chow ad libitum. Body weight was measured before examination. Ho-
mozygous mice weighed significantly less than wild-type mice as de-
scribed (Tables I and II) (3), and mesenteric fat mass was not appar-
ently different between IRS-1 deficient and wild-type mice.
 
Measurement of blood pressure.
 
Blood pressure was measured at
the tail artery in 21 homozygous mice and 18 wild-type mice (age, 58 mo)
under restraints using an automatic sphygmomanometer machine (9).
Basal blood pressure was measured under restraints in 16 homozy-
gous mice and 18 wild-type mice (age, 58 mo) using a perfluorocar-
bon cannula (KZ1101; Kent Scientific Co., CT) inserted into the fem-
oral artery under Nembutal-Na anesthesia (10). After 6 h of
cannulation, pulsatile blood pressure was measured under conscious
and unrestrained conditions in a quiet environment after a minimum
30-min acclimatization period between 20:00 and 24:00. Blood pres-
sure was measured every 2.5 s by a peak detector (AP-611G; Nihon-
Kohden, Tokyo, Japan). The data were stored on a tape recorder in
addition to heart rate measured using a tachometer (AT-601G; Ni-
hon-Kohden), and then stored in a computer (PC9801RX; NEC, To-
kyo, Japan). The mean value of each variable over a 1-h segment
composed of 1,440 sample points was calculated.
 
Vascular reactivity studies.
 
9 homozygous and 11 wild-type mice
(age, 56 mo) were decapitated, and a section of the thoracic aorta be-
tween the aortic arch and diaphragm was removed and placed in oxy-
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genated, modified Krebs-Henseleit solution (KHS). KHS consisted
of 118.0 mM NaCl, 4.7 mM KCl, 25.0 mM NaHCO
 
3
 
, 1.8 mM CaCl
 
2
 
,
1.2 mM NaH
 
2
 
PO
 
4
 
, 1.2 mM MgSO
 
4
 
, and 11.0 mM dextrose. The aorta
was cleaned of loosely adhering fat and connective tissue and cut into
rings (3 mm long). The tissue was placed in a well-oxygenated (95%
O
 
2
 
/5% CO
 
2
 
) bath of 10 ml KHS at 37
 
8
 
C with one end connected to a
tissue holder and the other to a force-displacement transducer (TB-
612T; Nihon-Kohden). The tissue was equilibrated for 60 min under
resting tension of 1.0 
 
g
 
, which is optimal for inducing the maximal
concentration in all vessels used. KHS in the bath was replaced every
20 min (11, 12).
Relaxation response to acetylcholine (ACh; Daiichi Pharmaceuti-
cal Co. Ltd., Tokyo, Japan) and sodium nitroprusside (SNP; Sigma
Chemical Co., St. Louis, MO) was expressed as a percentage of de-
creased tension in contractile force induced by 3 
 
3
 
 10
 
2
 
8
 
 to 1 
 
3
 
 10
 
2
 
7
 
 M
U46619, a derivative of thromboxane A
 
2
 
. For relaxation studies, the
aortic rings were precontracted with 3 
 
3
 
 10
 
2
 
8
 
 to 1 
 
3
 
 10
 
2
 
7
 
 M U46619.
This concentration produced 85–90% of the maximal response. Aor-
tic rings, which were weighed at the end of each experiment, were
precontracted with 3 
 
3
 
 10
 
2
 
8
 
 to 1 
 
3
 
 10
 
2
 
7
 
 M U46619 to ensure that
they could develop a tension of 
 
z 
 
100 mg/mg tissue in both age-
matched wild-type and homozygous mice. When U46619-induced
contraction reached a plateau, ACh (10
 
2
 
9
 
 to 10
 
2
 
5
 
 M) and SNP (10
 
2
 
9
 
to 10
 
2
 
5
 
 M) were added cumulatively. Each aortic ring was exposed to
only one relaxant agent.
 
Measurement of plasma lipids and fat loading test.
 
The blood of
2–3, 4–5, and 6–12-mo-old homozygous (
 
n
 
 5 
 
17) and wild-type mice
(
 
n
 
 5 
 
21) was collected after a 6-h fast from 9:00 a.m. to 2:00 p.m.
Blood was collected from the retroorbital plexus using heparin-
coated capillaries and transferred to an ice-cold tube. Plasma con-
centrations of triglycerides, cholesterol, and FFA were determined
enzymatically. HPLC was applied to show elution patterns with two
distinguished elution peaks of the two major lipoprotein classes, apo B
containing lipoproteins and HDL, which were used to determine
HDL-cholesterol levels (13).
After the 6-h fast, postheparin plasma of 6–12-mo-old homozy-
gous (
 
n
 
 5 
 
12) and wild-type (
 
n
 
 5 
 
16) mice was sampled 3 min after a
bolus injection of heparin (100 U/kg) into the external jugular vein.
Lipoprotein lipase (LPL) activity was assayed by the method de-
scribed by Nilsson-Ehle and Schotz (14). Postheparin plasma was as-
sayed in the presence or absence of 1 M NaCl in order to estimate
both LPL and hepatic triglyceride lipase (HL) activity. Lipase activity
in the presence of 1 M NaCl represented HL activity. LPL activity
was calculated by subtracting HL activity from lipase activity in the
absence of 1 M NaCl (15). LPL activity in adipose tissue derived from
the utero-ovarian region was assayed as described (15).
During the 6-h fast, at which time the mice were given ad libitum
access to water, olive oil (16.7 
 
m
 
l/g body wt) was introduced intragas-
trically using a cannula to 8–10-mo-old homozygous (
 
n
 
 5 
 
4) and wild-
type (
 
n
 
 5 
 
4) mice. After fat loading, 
 
z
 
 50 
 
m
 
l of blood was collected
serially at 0, 0.5, 1, 2, 3, and 5 h, and plasma triglyceride levels were
measured enzymatically (15).
 
Statistical analysis.
 
Data were analyzed by the Mann-Whitney U
test and expressed as mean
 
6
 
SD.
 
 P 
 
, 
 
0.05 was considered statistically
significant.
 
Results
 
Blood pressure.
 
Under restrained conditions, systolic arterial
blood pressure was significantly higher in homozygous mice
than in wild-type mice (147
 
6
 
11 vs. 123
 
6
 
24 mmHg,
 
 P 
 
, 
 
0.01)
(Table I), in contrast to unrestrained conditions in which sys-
tolic, diastolic, and mean arterial blood pressure were all sig-
nificantly higher in homozygous mice than in wild-type mice
(Table I). Systolic/diastolic pressure was 132
 
6
 
14/89
 
6
 
16 mmHg
in homozygous mice and 119
 
6
 
15/79
 
6
 
12 mmHg in wild-type
mice. Mean blood pressure was 110
 
6
 
12 mmHg in homozygous
mice and 99
 
6
 
10 mmHg in wild-type mice,
 
 P 
 
, 
 
0.01. Pulse
 
Table I. Restrained and Unrestrained Arterial Blood Pressure 
and Pulse Rate of IRS-1 Deficient and Wild-Type Mice
 
Homozygous Wild-Type
 
Restrained study (
 
n
 
 
 
5
 
 21) (
 
n
 
 
 
5
 
 18)
Body weight 15.6
 
6
 
2.5* 22.6
 
6
 
5.6
Systolic BP 147
 
6
 
11* 123
 
6
 
24
Unrestrained study (
 
n
 
 
 
5
 
 16) (
 
n
 
 
 
5
 
 18)
Body weight 18.8
 
6
 
2.6* 26.1
 
6
 
4.1
Systolic BP 132
 
6
 
14
 
‡
 
119
 
6
 
15
Diastolic BP 89
 
6
 
16
 
‡
 
79
 
6
 
12
Mean BP 110
 
6
 
12* 99
 
6
 
10
Pulse pressure 43
 
6
 
19 40
 
6
 
20
Pulse rate 634
 
6
 
77 652
 
6
 
41
Blood pressure was measured at a tail artery in 5–8-mo-old mice in a re-
strained condition. Furthermore, pulsatile blood pressure was measured
under conscious and unrestrained conditions in a quiet environment.
Data were expressed as mean
 
6
 
SD. *
 
P
 
 
 
,
 
 0.01, 
 
‡
 
P
 
 
 
,
 
 0.05 vs. wild-type.
 
Table II. Plasma Lipid Levels in IRS-1 Deficient and Wild-Type Mice
 
Body weight Triglyceride Cholesterol HDL FFA
 
g mg/dl mg/dl mg/dl
 
m
 
eq/liter
 
Homozygous mice
(months) 2–3 15.2
 
6
 
1.6* 51.2
 
6
 
23.8** 75.0
 
6
 
12.9 — —
4–5 15.8
 
6
 
1.3* 47.9
 
6
 
19.3* 76.0
 
6
 
11.3 — —
6–12 17.8
 
6
 
2.3* 53.1
 
6
 
22.5* 75.4
 
6
 
6.4 54.7
 
6
 
7.6
 
‡
 
503.7
 
6
 
122.5
(
 
n
 
 
 
5
 
 17) (
 
n
 
 
 
5
 
 17) (
 
n
 
 
 
5
 
 17) (
 
n
 
 
 
5 9) (n 5 21)
Wild-Type mice
(months) 2–3 21.062.0 33.1619.8 80.469.0 — —
4–5 23.861.3 28.468.0 81.9611.2 — —
6–12 24.561.6 33.866.7 79.669.7 68.968.5 529.76149.3
(n 5 21) (n 5 21) (n 5 21) (n 5 7) (n 5 14)
Data were analyzed by the Mann-Whitney U test and expressed as mean6SD. *P , 0.01, ‡P , 0.02 vs. wild-type.
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pressure and pulse rate did not differ significantly between ho-
mozygous and wild-type mice.
Vascular reactivity in aortic rings. The mechanisms under-
lying elevation in arterial blood pressure were examined in
order to elucidate vascular reactivity in aortic rings of IRS-1
deficient mice (Fig. 1). When the U46619 (3 3 1028 to 1 3 1027
M)-induced contraction reached a plateau, ACh (1029 to 1025 M)
was added cumulatively. ACh caused concentration-depen-
dent relaxation in aortic strips. This relaxation was signifi-
cantly reduced in aortic strips from homozygous mice com-
pared with wild-type mice. In contrast, relaxation caused by
SNP (1029 to 1025 M), which is an endothelium-independent
agent and activates soluble guanylate cyclase, did not differ
significantly between homozygous and wild-type mice.
Plasma lipid levels. Plasma triglyceride levels after the 6-h
fast in homozygous mice were significantly higher than in wild-
type mice at each measurement (Table II). This difference
was 1.6-fold in 2–3-mo-old mice (homozygous/wild-type:
51.2623.8/33.1619.8 mg/dl) and 1.7-fold in 4–5-mo-old mice
(homozygous/wild-type: 47.9619.3/28.468.0 mg/dl). Plasma
cholesterol and FFA levels did not differ significantly between
the two groups. HPLC analysis of the lipoprotein profiles re-
vealed a significant decrease in plasma HDL-cholesterol levels
(homozygous/wild-type: 54.767.6/68.968.5 mg/dl, Table II).
Fat loading test. Lipolysis of plasma triglycerides was ex-
amined by loading exogenous triglycerides as dietary fat (Fig.
2). The increase in plasma triglyceride level was significantly
greater in homozygous mice than in wild-type mice throughout
the experimental period. Plasma triglyceride peaked 2 h after
loading in both wild-type and homozygous mice. The peak
height in homozygous mice was significantly higher than in
wild-type mice (P , 0.02).
LPL activity in postheparin plasma after the 6-h fast was
significantly lower in homozygous mice than in wild-type mice
(Table III), whereas HL activity did not differ significantly be-
tween the two groups (data not shown). LPL activity in adi-
pose tissue was also significantly lower in homozygous mice
than in wild-type mice (Table III).
Discussion
Several researchers have suggested recently that insulin resis-
tance contributes to the pathogenesis of atherosclerosis (5–7,
16). In this study, we observed IRS-1 deficiency–induced insu-
lin resistance to lead to increased blood pressure and plasma
triglyceride levels, implicating involvement of insulin resis-
tance in both of these coronary risk factors. IRS-1 is the major
substrate of the insulin receptor kinase and mediates the signal
pathways of insulin and IGF-1 (1, 2), therefore the phenotype
of IRS-1 deficient mice reflects both defects of insulin and
IGF-1 signaling. IRS-1 deficient mice demonstrate growth re-
tardation and resistance to the glucose-lowering effect of insu-
lin (3, 4). Recent studies have shown insulin resistance in IRS-1
deficient mice to differ among tissues (17). IRS-1 plays a cen-
tral role in the signaling pathways of insulin in muscle and adi-
pose tissues. Furthermore, IRS-2 has been demonstrated to
compensate for IRS-1 deficiency in the liver of IRS-1 deficient
mice. Thus, insulin resistance in IRS-1 deficient mice appears
to be primarily due to resistance in muscle and adipose tissues.
Figure 1. Vascular reactivity in aortic strip. A section of the thoracic 
aorta between the aortic arch and diaphragm was used. The aortic 
rings were precontracted with an equieffective concentration of 
U46619. When the U46619-induced contraction reached a plateau, 
ACh and SNP were added cumulatively. The relaxation response to 
ACH (left) and SNP (right) was expressed as a percentage of the de-
creased tension in contractile force induced by 3 3 1028 to 1 3 1027 M 
U46619 (mean6SD).
Figure 2. Plasma triglyceride levels after fat loading test. After a 6-h 
fast, olive oil (16.7 ml/g body wt) was loaded intragastrically to ho-
mozygous (n 5 8) and wild-type (n 5 8) mice. Before and after fat 
loading, blood was collected serially, and plasma triglyceride levels 
were measured. The relative increase of plasma triglyceride levels af-
ter fat loading compared with that before fat loading was expressed 
as mean6SE.
Table III. LPL Activities in IRS-1 Deficient and
Wild-Type Mice
Postheparin plasma Adipose tissue
mmol FFA/h/ml mmol FFA/h/g
Homozygous mice 24.265.4* 3.361.7‡
(n 5 16) (n 5 7)
Wild-type mice 36.0613.9 5.762.3
(n 5 12) (n 5 7)
LPL activities in postheparin plasma and adipose tissue were measured
in 6–12-mo-old mice. Data were analyzed by the Mann-Whitney U test
and expressed as mean6SD. *P , 0.01, ‡P , 0.05 vs. wild-type.
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Epidemiological studies have demonstrated an association
between obesity, insulin resistance, and hypertension (18, 19).
Subsequent studies have suggested that essential hypertension
even in lean individuals is related to insulin resistance and hy-
perinsulinemia (20, 21). The mechanism associated with hy-
pertension in insulin resistance with hyperinsulinemia may be
related to skeletal muscle blood flow and relative skeletal mus-
cle fiber type (22), vascular endothelial function (23), in-
creased renal sodium reabsorption secondary to hyperin-
sulinemia (24), increased activity of the sympathetic nervous
system (25), or increased cellular cation transport (26). We es-
timated blood pressure in a nonobese animal model of insulin
resistance under restrained and unrestrained conditions. Blood
pressure under both conditions was significantly higher in IRS-1
deficient mice than in control mice. Thus, hypertension ap-
pears to occur as a result of pathophysiological abnormalities
caused by IRS-1 deficiency rather than increased sympathetic
activity during the experiment. It is possible that relatively low
body weight in IRS-1 deficient mice may influence blood pres-
sure. However, we found high blood pressure in IRS-1 defi-
cient mice as compared with body weight–matched control
mice. Furthermore, secondary hyperinsulinemia may have
been responsible for hypertension in the present animal
model. However, in our previous study, hyperinsulinemia did
not affect blood pressure in either normal Wistar or SHR rats
with two pancreas, despite a twofold increase in plasma insulin
after pancreas transplantation (8). Similar plasma insulin lev-
els were observed in the IRS-1 deficient mice (3) and therefore
are not likely to influence blood pressure. Thus, insulin resis-
tance appears to be a cause of hypertension in IRS-1 deficient
mice, although high insulin levels caused by insulin resistance
may play a role in the elevation of blood pressure.
Endothelium-dependent relaxation of the aorta was re-
duced in IRS-1 deficient mice, whereas endothelium-indepen-
dent relaxation did not differ between IRS-1 deficient and con-
trol mice. Nitric oxide, a potent vasodilator produced by
endothelial cells, has been proposed as the major form of en-
dothelium-dependent relaxing factor which mediates vascular
relaxation in response to ACh (27, 28). A recent study re-
ported that mice lacking the gene for endothelial nitric oxide
synthase show hypertension (29), suggesting that a resulting
impairment in endothelium-dependent vascular relaxation is
involved in the pathophysiology of hypertension. Impaired en-
dothelium-dependent vascular relaxation has been observed in
genetically diabetic rats (30), streptozotocin-induced diabetic
rats (31), and streptozotocin-induced diabetic mice (11). How-
ever, the role of insulin resistance in endothelium-dependent
vascular relaxation is not yet known. Since glucose tolerance is
normal in IRS-1 deficient mice (3), insulin resistance may be
responsible for impaired endothelium-dependent relaxation of
the aorta.
High plasma triglyceride and low plasma HDL-cholesterol
levels, which are inversely correlated, are common clinical
findings in the insulin-resistant states which include diabetes
mellitus, obesity, and syndrome X (32). Plasma triglyceride
levels increased 1.6-fold and plasma HDL-cholesterol levels
decreased 0.79-fold in IRS-1 deficient mice. Two underlying
mechanisms may explain the increase in plasma triglycerides
associated with insulin resistance in mutant mice: overproduc-
tion of VLDL in the liver and decreased clearance of VLDL
and chylomicrons (33, 34). Impaired insulin action not only
stimulates lipolysis, increasing delivery of FFA to the liver and
consequently increasing production of triglycerides, but also
reduces LPL activity. LPL is an enzyme located on the endo-
thelial surface of adipose tissue and skeletal and heart muscle
which hydrolyzes triglycerides in chylomicron and VLDL (35).
LPL activity of postheparin plasma and adipose tissue of IRS-1
deficient mice showed a significant reduction in this study,
leading to decreased hydrolysis of lipoprotein triglycerides. In
accordance with low LPL activity, a significantly greater incre-
ment in plasma triglyceride after administration of fat loading
was observed in IRS-1 deficient mice as compared with normal
mice. Plasma FFA levels are regulated by the transfer of FFA
between plasma and adipose tissue (36, 37), which involves
LPL and hormone-sensitive lipase (38). Lipolysis by hormone-
sensitive lipase in adipose tissue may be enhanced in the insu-
lin-resistant state of IRS-1 deficient mice (39). However,
plasma FFA levels did not increase in IRS-1 deficient mice.
Thus, hypertriglyceridemia in IRS-1 deficient mice may be
caused by defective hydrolysis of plasma triglycerides rather
than an increased delivery of FFA to the liver.
The present results suggest that insulin resistance plays an
essential role both in the clustering of coronary risk factors
such as hypertension and hypertriglyceridemia and in reduced
endothelium-dependent vascular relaxation. Endothelial dys-
function such as impaired endothelium-dependent vascular re-
laxation are considered to be closely related to the pathogene-
sis of atherosclerosis (28). Therefore, not only clustering of
coronary risk factors but also impaired endothelium-depen-
dent vascular relaxation may be involved in the progression of
atherosclerosis observed in insulin resistance.
References
1. Sun, X.J., P. Rothenberg, C.R. Kahn, J.M. Backer, E. Araki, P.A.
Wilden, D.A. Cahill, B.J. Goldstein, and M.F. White. 1991. Structure of the in-
sulin receptor substrate IRS-1 defines a unique signal transduction protein. Na-
ture. 352:73–77.
2. Kadowaki, T., S. Koyasu, E. Nishida, K. Tobe, T. Izumi, F. Takaku, H.
Sakai, I. Yahara, and M. Kasuga. 1987. Tyrosine phosphorylation of common
and specific sets of cellular proteins rapidly induced by insulin, insulin-like
growth factor I, and epidermal growth factor in an intact cell. J. Biol. Chem.
262:7342–7350.
3. Tamemoto, H., T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, T. Hayakawa,
Y. Terauchi, K. Ueki, Y. Kaburagi, S. Satoh, et al. 1994. Insulin resistance and
growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:
182–186.
4. Araki, E., M.A. Lipes, M.E. Patti, J.C. Bruning, B. Haag III, R.S.
Johnson, and C.R. Kahn. 1994. Alternative pathway of insulin signaling in mice
with targeted disruption of the IRS-1 gene. Nature. 372:186–190.
5. Kaplan, N.M. 1989. The deadly quartet. Arch. Intern. Med. 149:1514–
1520.
6. Reaven, G.M. 1988. Banting lecture 1988. Role of insulin resistance in
human disease. Diabetes. 37:1595–1607.
7. Zavaroni, I., E. Bonora, M. Pagliara, E. Dall’Aglio, L. Luchetti, G. Buon-
anno, P.A. Bonati, M. Bergonzani, L. Gnudi, M. Passeri, and G. Reaven. 1989.
Risk factors for coronary artery disease in healthy persons with hyperinsuline-
mia and normal glucose tolerance. N. Engl. J. Med. 320:702–706.
8. Abe, H., Y. Bandai, M. Makuuchi, Y. Idezuki, M. Nozawa, T. Oka, J.
Ohsuga, Y. Watanabe, T. Inaba, and N. Yamada. 1996. Hyperinsulinemia accel-
erates accumulation of cholesterol ester in aorta of rats with transplanted pan-
creas. Diabetologia. 39:1276–1283.
9. Yamakoshi, K., H. Shimazu, and T. Togawa. 1979. Indirect measurement
of instantaneous arterial blood pressure in the rat. Am. J. Physiol. 237:H632–
H637.
10. Kurihara, Y., H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, H. Na-
gai, T. Kuwaki, W.H. Cao, N. Kamada, K. Jishage, et al. 1994. Elevated blood
pressure and craniofacial abnormalities in mice deficient in endothelin-1. Na-
ture. 368:703–710.
11. Kamata, K., M. Sugiura, S. Kojima, and Y. Kasuya. 1996. Preservation
of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-
induced diabetic mice by the chronic administration of cholestyramine. Br. J.
Pharmacol. 118:385–391.
1788 Abe et al.
12. Miyata, N., K. Tsuchida, S. Okuyama, S. Otomo, K. Kamata, and T. Ka-
suya. 1992. Age-related changes in endothelium-dependent relaxation in aorta
from genetically diabetic WBN/Kob rats. Am. J. Physiol. 262:H1104–H1109.
13. Shimano, H., N. Yamada, N. Katsuki, M. Shimada, T. Gotoda, K.
Harada, T. Murase, C. Fukazawa, F. Takaku, and Y. Yazaki. 1992. Overexpres-
sion of apolipoprotein E in transgenic mice: a marked reduction in plasma lipo-
proteins except high density lipoprotein. Proc. Natl. Acad. Sci. USA. 89:1750–
1754.
14. Nilsson-Ehle, P., and M.C. Schotz. 1976. A stable, radioactive substrate
emulsion for assay of lipoprotein lipase. J. Lipid Res. 17:536–541.
15. Shimada, M., H. Shimano, T. Gotoda, K. Yamamoto, M. Kawamura, T.
Inaba, Y. Yazaki, and N. Yamada. 1993. Overexpression of human lipoprotein
lipase in transgenic mice. J. Biol. Chem. 268:17924–17929.
16. Williams, B. 1994. Insulin resistance: the shape of things to come. Lan-
cet. 344:521–524.
17. Yamauchi, T., K. Tobe, H. Tamemoto, K. Ueki, T. Kaburagi, R. Yama-
moto-Honda, Y. Takahashi, F. Yoshizawa, S. Aizawa, Y. Akanuma, et al. 1996.
Insulin signaling and insulin actions in the muscles and livers of insulin-resis-
tant, insulin receptor substrate 1-deficient mice. Mol. Cell. Biol. 16:3074–3084.
18. Modan, M., H. Halkin, S. Almog, A. Lusky, A. Eshkil, M. Shefi, A.
Shitrit, and Z. Fuchs. 1985. Hyperinsulinemia: a link between hypertension,
obesity and glucose intolerance. J. Clin. Invest. 75:809–817.
19. Lucas, C.P., J.A. Estigarribia, L.L. Darga, and G.M. Reaven. 1985. Insu-
lin and blood pressure in obesity. Hypertension. 7:702–706.
20. Ferrannini, E., G. Buzzigoli, R. Bonadonna, M.A. Giorico, M. Oleggini,
L. Graziadei, R. Pedrinelli, L. Brandi, and S. Bevilacqua. 1987. Insulin resis-
tance in essential hypertension. N. Engl. J. Med. 15:350–357.
21. Bonora, E., I. Zavaroni, O. Alpi, A. Pezzarossa, F. Bruschi, E.
Dall’Aglio, L. Guerra, C. Coscelli, and U. Butturini. 1987. Relationship be-
tween blood pressure and plasma in insulin in non-obese and obese non-dia-
betic subjects. Diabetologia. 30:719–723.
22. Lillioja, S., A.A. Young, and C.L. Culter. 1987. Skeletal muscle capillary
density and fiber type are possible determinants of in vivo insulin resistance in
man. J. Clin. Invest. 80:415–424.
23. Steinberg, H.O., G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron.
1994. Insulin mediated skeletal muscle vasodilation is nitric oxide dependent. A
novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94:1172–
1179.
24. DeFronzo, R.A. 1981. The effect of insulin on renal sodium metabolism:
a review with clinical implications. Diabetologia. 21:165–171.
25. Rowe, J.W., J.B. Young, K.L. Minaker, A.L. Stevens, J. Pallotta, and L.
Landsberg. 1981. Effect of insulin and glucose infusions on sympathetic nervous
system activity in normal man. Diabetes. 30:219–225.
26. Moore, R.D. 1983. Effects of insulin upon ion transport. Biochim. Bio-
phys. Acta. 737:1–49.
27. Palmer, R.M.J., A.G. Ferrige, and S. Moncada. 1987. Nitric oxide re-
lease accounts for the biological activity of endothelium-derived relaxing fac-
tor. Nature. 327:524–526.
28. Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: physi-
ology, pathology, and pharmacology. Pharmacol. Rev. 43:109–142.
29. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A.
Bevan, and M.C. Fishman. 1995. Hypertension in mice lacking the gene for en-
dothelial nitric oxide synthase. Nature. 377:239–242.
30. Meraji, S., L. Jayakody, P.J. Senaratne, A.B.R. Thomson, and T. Kappa-
goda. 1987. Endothelium-dependent relaxation in aorta of BB rat. Diabetes. 36:
978–981.
31. Kamata, K., N. Miyata, and Y. Kasuya. 1989. Impairment of endothe-
lium-dependent relaxation and changes in levels of cyclic GMP in aorta from
streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97:614–618.
32. Howard, B.V. 1987. Lipoprotein metabolism in diabetes mellitus. J.
Lipid Res. 28:613–628.
33. Reaven, E.P., and G.M. Reaven. 1974. Mechanisms for development of
diabetic hypertriglyceridemia in streptozotocin-treated rat. Effect of diet and
duration of insulin deficiency. J. Clin. Invest. 54:1167–1178.
34. Shimada, M., S. Ishibashi, T. Gotoda, M. Kawamura, K. Yamamoto, T.
Inaba, K. Harada, J. Ohsuga, S. Perrey, Y. Yazaki, and N. Yamada. 1995. Over-
expression of human lipoprotein lipase protects diabetic transgenic mice from
diabetic hypertriglyceridemia and hypercholesterolemia. Arterioscler. Thromb.
Vasc. Biol. 15:1688–1694.
35. Eckel, R.H. 1989. Lipoprotein lipase: a multifunctional enzyme relevant
to common metabolic diseases. N. Engl. J. Med. 320:1060–1068.
36. Ruderman, N.B., C.J. Toews, and E. Shafrir. 1969. Role of free fatty ac-
ids in glucose homeostasis. Arch. Intern. Med. 123:299–313.
37. Pelkonen, R., T.A. Miettinen, M.R. Taskinen, and E.A. Nikkila. 1968.
Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glu-
cose utilization and plasma insulin. Diabetes. 17:76–82.
38. Coppack, S.W., R.D. Evans, R.M. Fisher, K.N. Frayn, G.F. Gibbons,
S.M. Humphreys, M.L. Kirk, J.L. Potts, and T.D.R. Hockaday. 1992. Adipose
tissue metabolism in obesity: lipase action in vivo before and after a mixed
meal. Metabolism. 41:264–272.
39. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the
control of white and brown fat cell function. J. Lipid Res. 34:1057–1091.
